{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Chad", "organization": "", "rank": 1, "lastname": "BRAY"}], "original": "By CHAD BRAY"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"main": "Hikma Pharmaceuticals Cuts Offer Price for Generic Drug Maker Roxane"}, "print_page": null, "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Boehringer Ingelheim GmbH", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Hikma Pharmaceuticals PLC", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Amman (Jordan)", "is_major": "N", "rank": "5", "name": "glocations"}, {"value": "Germany", "is_major": "N", "rank": "6", "name": "glocations"}, {"value": "United States", "is_major": "N", "rank": "7", "name": "glocations"}], "snippet": "Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim\u2019s generic drugs business in the U.S. had lower-than-expected sales.", "source": "The New York Times", "lead_paragraph": "Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim\u2019s generic drugs business in the U.S. had lower-than-expected sales.", "word_count": "394", "pub_date": "2016-02-11T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/02/11/business/dealbook/hikma-pharmaceuticals-cuts-offer-price-for-generic-drug-maker-roxane.html", "_id": "56bb077238f0d831a8916982"}